258 related articles for article (PubMed ID: 35679369)
1. Cellular and Engineered Organoids for Cardiovascular Models.
Thomas D; Choi S; Alamana C; Parker KK; Wu JC
Circ Res; 2022 Jun; 130(12):1780-1802. PubMed ID: 35679369
[TBL] [Abstract][Full Text] [Related]
2. Heart in a dish - choosing the right in vitro model.
Drakhlis L; Zweigerdt R
Dis Model Mech; 2023 May; 16(5):. PubMed ID: 36825553
[TBL] [Abstract][Full Text] [Related]
3. An evidence appraisal of heart organoids in a dish and commensurability to human heart development in vivo.
Thomas D; de Jesus Perez VA; Sayed N
BMC Cardiovasc Disord; 2022 Mar; 22(1):122. PubMed ID: 35317745
[TBL] [Abstract][Full Text] [Related]
4. Perspectives for Future Use of Cardiac Microtissues from Human Pluripotent Stem Cells.
Arslan U; Orlova VV; Mummery CL
ACS Biomater Sci Eng; 2022 Nov; 8(11):4605-4609. PubMed ID: 35315663
[TBL] [Abstract][Full Text] [Related]
5. Challenges and opportunities for the next generation of cardiovascular tissue engineering.
Cho S; Discher DE; Leong KW; Vunjak-Novakovic G; Wu JC
Nat Methods; 2022 Sep; 19(9):1064-1071. PubMed ID: 36064773
[TBL] [Abstract][Full Text] [Related]
6. From Spheroids to Organoids: The Next Generation of Model Systems of Human Cardiac Regeneration in a Dish.
Scalise M; Marino F; Salerno L; Cianflone E; Molinaro C; Salerno N; De Angelis A; Viglietto G; Urbanek K; Torella D
Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34947977
[TBL] [Abstract][Full Text] [Related]
7. Recent advances in pluripotent stem cell-derived cardiac organoids and heart-on-chip applications for studying anti-cancer drug-induced cardiotoxicity.
Liu S; Fang C; Zhong C; Li J; Xiao Q
Cell Biol Toxicol; 2023 Dec; 39(6):2527-2549. PubMed ID: 37889357
[TBL] [Abstract][Full Text] [Related]
8. From engineered heart tissue to cardiac organoid.
Cho J; Lee H; Rah W; Chang HJ; Yoon YS
Theranostics; 2022; 12(6):2758-2772. PubMed ID: 35401829
[TBL] [Abstract][Full Text] [Related]
9. Three-dimensional cardiac models: a pre-clinical testing platform.
Groen E; Mummery CL; Yiangou L; Davis RP
Biochem Soc Trans; 2024 Jun; 52(3):1045-1059. PubMed ID: 38778769
[TBL] [Abstract][Full Text] [Related]
10. Engineered models of the human heart: Directions and challenges.
Stein JM; Mummery CL; Bellin M
Stem Cell Reports; 2021 Sep; 16(9):2049-2057. PubMed ID: 33338434
[TBL] [Abstract][Full Text] [Related]
11. Heart Organoids and Engineered Heart Tissues: Novel Tools for Modeling Human Cardiac Biology and Disease.
Lewis-Israeli YR; Wasserman AH; Aguirre A
Biomolecules; 2021 Aug; 11(9):. PubMed ID: 34572490
[TBL] [Abstract][Full Text] [Related]
12. Recapitulating human cardio-pulmonary co-development using simultaneous multilineage differentiation of pluripotent stem cells.
Ng WH; Johnston EK; Tan JJ; Bliley JM; Feinberg AW; Stolz DB; Sun M; Wijesekara P; Hawkins F; Kotton DN; Ren X
Elife; 2022 Jan; 11():. PubMed ID: 35018887
[TBL] [Abstract][Full Text] [Related]
13. In vitro models of the human heart.
Hofbauer P; Jahnel SM; Mendjan S
Development; 2021 Aug; 148(16):. PubMed ID: 34423833
[TBL] [Abstract][Full Text] [Related]
14. What can we learn from kidney organoids?
Dorison A; Forbes TA; Little MH
Kidney Int; 2022 Nov; 102(5):1013-1029. PubMed ID: 35970244
[TBL] [Abstract][Full Text] [Related]
15. Reconstructing the heart using iPSCs: Engineering strategies and applications.
Cho S; Lee C; Skylar-Scott MA; Heilshorn SC; Wu JC
J Mol Cell Cardiol; 2021 Aug; 157():56-65. PubMed ID: 33895197
[TBL] [Abstract][Full Text] [Related]
16. Engineered heart tissue models from hiPSC-derived cardiomyocytes and cardiac ECM for disease modeling and drug testing applications.
Goldfracht I; Efraim Y; Shinnawi R; Kovalev E; Huber I; Gepstein A; Arbel G; Shaheen N; Tiburcy M; Zimmermann WH; Machluf M; Gepstein L
Acta Biomater; 2019 Jul; 92():145-159. PubMed ID: 31075518
[TBL] [Abstract][Full Text] [Related]
17. Fitting tissue chips and microphysiological systems into the grand scheme of medicine, biology, pharmacology, and toxicology.
Watson DE; Hunziker R; Wikswo JP
Exp Biol Med (Maywood); 2017 Oct; 242(16):1559-1572. PubMed ID: 29065799
[TBL] [Abstract][Full Text] [Related]
18. Cardiac Organoids: A 3D Technology for Modeling Heart Development and Disease.
Zhu L; Liu K; Feng Q; Liao Y
Stem Cell Rev Rep; 2022 Dec; 18(8):2593-2605. PubMed ID: 35525908
[TBL] [Abstract][Full Text] [Related]
19. Advances in 3D Organoid Models for Stem Cell-Based Cardiac Regeneration.
Martin M; Gähwiler EKN; Generali M; Hoerstrup SP; Emmert MY
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982261
[TBL] [Abstract][Full Text] [Related]
20. Engineering approaches for cardiac organoid formation and their characterization.
Joddar B; Natividad-Diaz SL; Padilla AE; Esparza AA; Ramirez SP; Chambers DR; Ibaroudene H
Transl Res; 2022 Dec; 250():46-67. PubMed ID: 35995380
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
